2023 XJT• Global Summer School

Pharmacoeconomics and Policy Summer Camp Enrollment

（XJTISS）

【Course overview】

In recent years, pharmacoeconomic evaluation and health technology assesment have become an indispensable part of China's medical and health system reform, especially for the national basic medical insurance drug list and the national essential drug list. As an interdisciplinary discipline, pharmaceutical economics and policy aims to guide the use of limited drug resources to maximize health outcomes. It plays an important role in drug development, production, use, post-marketing monitoring, and health insurance access.

School of Pharmacy, Xi 'an Jiaotong University, Center for Drug Safety and Policy Research Center (CDSP), Xi'an Jiaotong University, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Northwest China Chapter jointly organized the 2023 XJT•Global Summer School: Pharmacoeconomics and Policy Summer Camp. We have invited internationally renowned professors from Harvard Medical School, Tulane University, University of Melbourne, McMaster University, The Chinese University of Hong Kong, Peking University, and Xi’an Jiaotong University to form the teaching team. With a focus on pharmacoeconomics and policy, the Summer School will provide an interdisciplinary academic experience and rich international exchange experience for students from all over the world.

【Teaching Professors】

Dennis Ross-Degnan

Dennis Ross-Degnan is Associate Professor at the Department of Population Medicine at Harvard Medical School. He holds a doctorate in health policy and management from Harvard School of Public Health. For over thirty years, Dr. Ross-Degnan‘s work has focused on improving health systems in the US and low- and middle-income countries, including research on behavioral and systems factors that determine use of medicines, impacts of health and pharmaceutical policies on utilization and clinical outcomes, and appropriate methods for health systems research. He has served as lead or senior investigator on many international and domestic research studies to evaluate health systems initiatives to improve quality and outcomes of care, including studies examining: different forms of interactive education; pharmaceutical and insurance benefit design; systems interventions to improve ARV adherence; high deductible health plans for patients with chronic illness; using hospital-based community health workers to reduce hospital readmissions; outreach to health providers and patients to improve utilization; and systems interventions in low resource settings to promote appropriate prescribing and use of medicines. He is one of the most influential scholars in the field of international drug policy, published more than 300 research papers with H-index of 73, including some published in The Lancet Global Health and The Lancet Infectious Diseases.

Lizheng Shi

Lizheng Shi, the endowed Regents Associate Professor in Department of Globa Health Systems and Development at School of Public Health and Tropical Medicine of Tulane University. He is also jointly appointed as clinical faculty in the Departments of Internal Medicine and Psychiatry at School of Medicine of Tulane University. He was trained as an economist (M.A. in Economics 1999 PhD in pharmaceutical economics and policy 2001) through the University of Southern California. His current research interests include comparative effectiveness research, health technology assessment (cost of illness. Cost-benefit. Cost-effectiveness. Cost utility) and health care quality, access, and evaluation. He is also interested in health informatics interventions to address health systems issues regarding quality and safety of patient care.

Yu Fang

Yu Fang, is Chairman of ISPOR Northwest China Chapter. Young Changjiang Scholar from the Ministry of Education, China. Vice-Dean, School of Pharmacy, Xi’an Jiaotong University. Director of Center for Drug Safety and Policy Research, Xi’an Jiaotong University. He is engaged in pharmaceutical administration and pharmacoeconomics research, and has rich experience in organizing drug policy surveys and PE/HTA analysis. Professor Fang has published more than 200 research papers, including some published in The Lancet Infectious Diseases, The Lancet Global Health and British Medical Journal as the first or corresponding author.

Yuting Zhang

Yuting Zhang is Professor of Health Economics at the University of Melbourne, and an expert on economic evaluations of health policy and healthcare reforms. She develops and evaluates novel strategies to improve health insurance design, health system productivity, and population health. Her research focuses on economic evaluations of health insurance market, healthcare system, and health policy. Her work uses advanced economic modelling and quantitative analyses of large data sets to study the impact of health policy and the choices of individuals. Her research has been published in leading medicine, health policy, and economics journals such as the New England Journal of Medicine, and has been featured in ABC news, the New York Times, the Wall Street Journal, and on National Public Radio.

Feng Xie

Feng Xie is Professor in the Department of Clinical Epidemiology and biostatistics at McMaster University School of Medicine and a member of the Centre for Health Economics and Policy Analysis, The research field focuses on the use of evidence-based medicine methods to analyze the effectiveness and cost of new drugs and medical devices. He has led or participated in more than 100 international and Canadian government and enterprise funded research projects. Among them, he has led dozens of projects funded by the European Foundation for Quality of Life Research, the Canadian National Institutes of Health, the Canadian Federal Centre for Health Technology Assessment and the Ontario Ministry of Health.

YOU Hoi-sze, Joyce

You Hoi-sze is Assistant Dean and Professor of the School of Pharmacy at the Chinese University of Hong Kong. Her areas of expertise are medical economics, decision trees and Markov model algorithms, and infectious diseases. She has spent many years researching the cost and effectiveness of medical technologies for diagnosis, treatment, and prevention, translating innovative medical practices and technologies into cost-effective clinical protocols, and developing research methods to simulate treatment outcomes.

Xiaodong Guan

Xiaodong Guan is Associate Professor and Director of the Department of Pharmaceutical Management and Clinical Pharmacology, School of Pharmacy, Peking University. He is also a researcher at the International Research Center for Pharmaceutical Management of Peking University and an academic member of the Key Laboratory of Pharmacovigilance Research and Evaluation of the Drug Evaluation Center of the State Drug Administration. His research interests are equitable access and rational use of medicines. In Nature Reviews Clinical Oncology, JAMA Internal Medicine, JAMA Network Open, Clinical Microbiology and Infection, WHO Bulletin, Cancer Communication, BMJ Global Health and other journals have published more than 170 academic papers, providing intellectual support and scientific evidence for China’s national drug policy and rational drug use.

Dennis Xuan

Dennis Xuan is a current PhD Candidate at the Tulane University School of Public Health and Tropical Medicine at New Orleans within the department of healthcare policy and management. He also has a master’s degree in public health from the University of North Carolina Gillings School of Public Health at Chapel Hill. Dennis has extensive training, work experience, and expertise in the creation and dissemination of health economic research, particularly in cost-effectiveness analysis, budget impact models, and patient reported outcomes research. He has also published several peer-reviewed articles and international conference abstracts across topics such as Pharmacoeconomics, HTA, and real-world data analysis.

【Curriculum system】

Pharmacoeconomics and policy evaluation is an important policy to promote the “One Health” strategy in the world, including drug policy and drug supply security, access to innovative drugs for medical insurance, pharmacoeconomics and health technology assessment, and clinical comprehensive evaluation of drugs, etc. Therefore, this Summer Camp focuses on the frontier of pharmacoeconomics and related policies, which will promote the in-depth integration and development of medicine, and share the research and practice of drug value assessment, drug market access, new model methods and the real-world studies. It will provide a high level platform for international exchange for global college students and related researchers in this field.

Upon successful completion of all lectures, students can apply for a summer course Certificate of Completion issued by Xi’an Jiaotong University.

【Application】

Please register by filling out the application form by scanning the below QRcode. Application deadline is July 19th, 2023.

Please scan the code to join the course group (Wechat)

【Module】

Free Course in English

Synchronous online and offline teaching (Tencent Meeting)

【Contact Information】

Tel: 17349018028 Jing Li　　Email: annieli3@icloud.com

School of Pharmacy, Xi 'an Jiaotong University

Center for Drug Safety and Policy Research Center, Xi 'an Jiaotong University (CDSP)

International Society for Pharmacoeconomics and Outcomes Research, Northwest China Chapter